Status:

RECRUITING

Biomechanical Footwear as a Non-invasive Alternative and Supplement to Total Knee Replacement

Lead Sponsor:

Geisinger Clinic

Collaborating Sponsors:

Apos Medical and Sports Technology Ltd.

Conditions:

Osteoarthritis, Knee

Eligibility:

All Genders

45-80 years

Phase:

NA

Brief Summary

Osteoarthritis (OA), the most common type of arthritis, affects more than 32.5 million adults in the United States. It is also among the most expensive condition to treat when joint replacement surger...

Detailed Description

Osteoarthritis (OA), the most common type of arthritis, affects more than 32.5 million adults in the United States. It is also among the most expensive condition to treat when joint replacement surger...

Eligibility Criteria

Inclusion

  • Men or non-pregnant women
  • Between ages 45 and 80, inclusive
  • ACR clinical criteria for OA of the knee
  • Symptomatic uni- or bilateral OA of the knee for at least six months
  • Radiological criteria: X-rays showing tibiofemoral knee osteoarthritis defined as at least Kellgren and Lawrence Grade 2
  • At least a moderate NPRS pain score at baseline (≥5)
  • Score of 1-3 based on the American Society of Anesthesiologists Physical Status Classification System
  • Willing and able to read, comprehend, and sign the study informed consent form in English prior to study specific procedure

Exclusion

  • Body Mass Index (BMI) \> 40
  • History of an inflammatory rheumatic disease
  • Non-knee musculoskeletal pain that is more severe than the knee pain
  • Corticosteroids injections in the knees in the previous 6 weeks
  • Previous major surgery to the knee such as osteotomy, hemiprosthesis, unilateral total joint replacement excluding knee arthroscopy \> 6 months
  • Patients with Geisinger Health Plan insurance for whom Apos is a covered treatment
  • Patients with a recent history (\<3 months) of a mental health condition, such as depression or anxiety
  • Problems with balance (\>2 unexplained falls within the last 12 months; experiencing regular dizziness that has caused a trip or fall; using a walking aid to get around such as a rollator, cane, walker)

Key Trial Info

Start Date :

July 22 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2026

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04732962

Start Date

July 22 2021

End Date

March 1 2026

Last Update

April 30 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Geisinger Medical Center

Danville, Pennsylvania, United States, 17822

2

Geisinger - Orthopaedics Wilkes-Barre

Wilkes-Barre, Pennsylvania, United States, 18702